{
     "PMID": "16757155",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20070226",
     "LR": "20131121",
     "IS": "0924-977X (Print) 0924-977X (Linking)",
     "VI": "17",
     "IP": "3",
     "DP": "2007 Feb",
     "TI": "Effect of antidepressant drugs on 6-OHDA-treated mice in the FST.",
     "PG": "187-93",
     "AB": "There is growing evidence suggesting that dopamine could be indirectly involved in the appearance of behavioural effects of antidepressants. In this study, we induced a partial (over 70%) and non-reversible depletion of dopamine-containing neurons in mice by i.c.v. infusion of 6-OHDA. Then, we compared the antidepressant-like effect of drugs (citalopram, paroxetine, desipramine and imipramine) with or without dopamine depletion in the mice forced swimming test. Our results clearly show that lesion with 6-OHDA does not modify the response of mice to desipramine and imipramine, whereas dopamine depletion abolished the antidepressant-like effect of citalopram and paroxetine. It could then be suggested that antidepressant-like effect of selective serotonin reuptake inhibitors (paroxetine and citalopram) in the mice FST requires the activation of dopaminergic pathways to occur.",
     "FAU": [
          "Chenu, F",
          "Dailly, E",
          "Bourin, M"
     ],
     "AU": [
          "Chenu F",
          "Dailly E",
          "Bourin M"
     ],
     "AD": "Neurobiologie de l'Anxiete et de la Depression, EA 3256, Faculte de Medecine, 1 rue Gaston Veil, 44035 Nantes Cedex, France.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20060606",
     "PL": "Netherlands",
     "TA": "Eur Neuropsychopharmacol",
     "JT": "European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology",
     "JID": "9111390",
     "RN": [
          "0 (Antidepressive Agents)",
          "0 (Antidepressive Agents, Second-Generation)",
          "0 (Antidepressive Agents, Tricyclic)",
          "0 (Biogenic Monoamines)",
          "0 (Dopamine Uptake Inhibitors)",
          "0DHU5B8D6V (Citalopram)",
          "41VRH5220H (Paroxetine)",
          "8HW4YBZ748 (Oxidopamine)",
          "OGG85SX4E4 (Imipramine)",
          "TG537D343B (Desipramine)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Antidepressive Agents/*pharmacology",
          "Antidepressive Agents, Second-Generation/pharmacology",
          "Antidepressive Agents, Tricyclic/pharmacology",
          "Biogenic Monoamines/metabolism",
          "Cerebral Cortex/metabolism",
          "Citalopram/pharmacology",
          "Depression/*psychology",
          "Desipramine/pharmacology",
          "Dopamine Uptake Inhibitors/pharmacology",
          "Hippocampus/metabolism",
          "Hypothalamus/metabolism",
          "Imipramine/pharmacology",
          "Injections, Intraventricular",
          "Male",
          "Mice",
          "Neostriatum/metabolism",
          "Oxidopamine/administration & dosage/*pharmacology",
          "Paroxetine/pharmacology",
          "Swimming/*psychology"
     ],
     "EDAT": "2006/06/08 09:00",
     "MHDA": "2007/02/27 09:00",
     "CRDT": [
          "2006/06/08 09:00"
     ],
     "PHST": [
          "2005/11/25 00:00 [received]",
          "2006/03/22 00:00 [revised]",
          "2006/04/04 00:00 [accepted]",
          "2006/06/08 09:00 [pubmed]",
          "2007/02/27 09:00 [medline]",
          "2006/06/08 09:00 [entrez]"
     ],
     "AID": [
          "S0924-977X(06)00074-5 [pii]",
          "10.1016/j.euroneuro.2006.04.006 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Eur Neuropsychopharmacol. 2007 Feb;17(3):187-93. doi: 10.1016/j.euroneuro.2006.04.006. Epub 2006 Jun 6.",
     "term": "hippocampus"
}